Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Rotavirus Prophylaxis Market from 2024 to 2033?

The rotavirus prophylaxis market size is expected to grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. This growth can be attributed to vaccine access and equity, emerging rotavirus strains, R&D investments, and public health preparedness.

The rotavirus prophylaxis market is expected to see significant growth, reaching $13.24 billion by 2028, with a CAGR of 10.0%. This growth is driven by the gastrointestinal disease burden, global healthcare expansion, vaccination programs, and vaccine confidence. Major trends include next-generation vaccines, combination vaccines, delivery innovations, and global immunization efforts.

Claim Your Free Sample of the Global Rotavirus Prophylaxis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13045&type=smp

The growth in vaccine courses is likely to drive the rotavirus prophylaxis market. Vaccine courses, specific doses designed to protect against disease, strengthen immunity and prevent rotavirus infection. In January 2022, a UNICEF report indicated that 5.71 million courses of RV1-5 rotavirus vaccines were produced in 2022, with projections for 9.31 million by 2028. Likewise, 5.29 million courses of RV5-2 lyophilized vaccines were produced in 2022, with a forecasted increase to 6.13 million by 2028. Thus, the rising number of vaccine courses is boosting the rotavirus prophylaxis market.

1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Major companies in the rotavirus prophylaxis market are focused on developing vaccines to meet customer demands. The approval process for vaccines involves several stages of development and testing to ensure their safety and efficacy in preventing rotavirus, particularly in infants and young children. For example, in November 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology firm, received approval from the FDA for an oral-dosing applicator-only version of ROTARIX, a rotavirus vaccine that prevents gastroenteritis caused by G1 and non-G1 strains (G3, G4, and G9) in infants. This formulation is entirely liquid and requires no reconstitution before use. Both the lyophilized and liquid versions of ROTARIX are administered orally in a two-dose series, containing the same live, human-attenuated rotavirus strain and produced using similar techniques.

Order Now for Fast Delivery of Your Rotavirus Prophylaxis Market Report!

https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

North America was the largest region in the compression garments and stockings market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the compression garments and stockings market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Rotavirus Prophylaxis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the rotavirus prophylaxis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Rotavirus Prophylaxis Market Include

1. Rotavirus Prophylaxis Market Executive Summary

2. Rotavirus Prophylaxis Market Segments

3. Rotavirus Prophylaxis Market Size And Template Market Growth Rate

4. Key Rotavirus Prophylaxis Market Trends

5. Major Rotavirus Prophylaxis Market Drivers

……

25. Key Mergers And Acquisitions In The Rotavirus Prophylaxis Market

26. Top Rotavirus Prophylaxis Companies

27. Rotavirus Prophylaxis Market Opportunities And Strategies

28. Rotavirus Prophylaxis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

DTP Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: